Treatment of Interface Fluid Syndrome after Laser-Assisted In Situ Keratomileusis with Descemet Membrane Endothelial Keratoplasty in Three Patients with Corneal Endothelial Dysfunction
Descemet Membrane Endothelial Keratoplasty (DMEK) has become a first-line treatment in corneal endothelial diseases owing to its exceptional clinical outcomes and low complication rates. Thanks to its refractive predictability and the ability to reshape the superficial cornea, DMEK is now also consi...
| Autores: | , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2023 |
| País: | España |
| Institución: | Universidad Católica de Valencia San Vicente Mártir |
| Repositorio: | RIUCV. Repositorio de la Universidad Católica de Valencia San Vicente Mártir |
| Idioma: | inglés |
| OAI Identifier: | oai:riucv.ucv.es:20.500.12466/4568 |
| Acceso en línea: | http://hdl.handle.net/20.500.12466/4568 |
| Access Level: | acceso abierto |
| Palabra clave: | Descemet membrane Endothelial keratoplasty Interface fluid Keratomileusis 3201.09 Oftalmología |
| Sumario: | Descemet Membrane Endothelial Keratoplasty (DMEK) has become a first-line treatment in corneal endothelial diseases owing to its exceptional clinical outcomes and low complication rates. Thanks to its refractive predictability and the ability to reshape the superficial cornea, DMEK is now also considered for managing cases with endothelial decompensation following previous refractive procedures. This article reviews the clinical outcomes of DMEK in three patients with Interface Fluid Syndrome (IFS), a complication of laser-assisted in situ keratomileusis (LASIK) in which endothelial failure can play a major role. |
|---|